GSK, Human Genome win Canadian OK for Benlysta; Eisai to submit Zonegran for new use;

@FiercePharma: Novartis mulls IPO on China's planned int'l board. News | Follow @FiercePharma

> GlaxoSmithKline and Human Genome Sciences have been boosted by another approval for their lupus drug Benlysta, this time in Canada. Piece

> Gilead Sciences extended its partnership with four Indian drug companies--Ranbaxy, Hetero, Matrix and Strides Arcolab--to produce and market three HIV/AIDS drugs added to the international patent pool. Article

> On the back of positive late-stage data, Eisai says it plans to submit its epilepsy drug Zonegran to European regulators as a first-line monotherapy for the neurological condition. News

> GlaxoSmithKline says jobs at a 280-employee Scottish factory are safe, after local concerns were raised following cuts in Ireland. Report

> Eli Lilly has donated $1 million toward for the construction of a new Indianapolis hospital. Story

> India asked China to speed up authorization for its pharmaceutical firms to gain entry to the country's vast market, stating that Chinese individuals would benefit from the opportunity to buy comparatively low-priced medications. Story

> Dr Reddy's got the FDA nod for its version of Arixtra, GlaxoSmithKline's injectable treatment for acute deep vein thrombosis. Piece

> Women who have just given birth should wait at least three weeks before they start using birth control pills because of the risk of serious, potentially fatal blood clots, public health officials announced last week. Item

> U.S. budget negotiators have not found a way to avert a government default, but with their ideas to cut Medicare and Medicaid they have provoked opposition from almost every major group that represents beneficiaries and health care providers. Article

Biotech News

@FierceBiotech: Superbug antibiotics: New drugs advance amid R&D investment shortfall. Special Report | Follow @FierceBiotech

> J&J's success with Hep C partners might hit a snag. Article

> Transcept Pharma expects bad news on insomnia drug from FDA. Piece

Drug Delivery News

> Alnylam applies for trial of RNAi delivery tech for high cholesterol. Item

> MIT's Langer discusses targeted drug delivery. Report

> EnGeneIC, scientists search for antibodies to grab hold of tumors. Item

> Multitasking gel, polymer chain could deliver many drugs at once. Article

> Instant nano-delivery vehicle for brain cancer, just add water. Story

Medical Device News

> Kinetic Concepts to be bought for $4.98B. News

> Medtronic asks for $2.5M to expand Jacksonville ops. Article

> Shuren talks CDRH performance, staffing in Boston. News

> Representatives discuss Scottish device, diagnostic biz. Story

And Finally... The placebo effect is alive and well for common cold sufferers who turn to medications for relief. Report

Suggested Articles

BMS’s Opdivo has plenty of competition in its current bladder cancer indication—so it’s hoping to strike out on its own in a new area of the disease.

The Japanese approval, under the brand name Jyseleca, came a month after an FDA complete response letter that asked Gilead for more data.

The Trump Administration has opened the doors for Florida and other states to import prescription drugs from Canada—despite industry objections.